¥[³t¨ú±o¥ý¶iÀùÃÄ¡@°·«O¸p»P­^°êNICEñ¦X§@¨ó©w

2023-05-26 1226

½ÃºÖ³¡°·«O¸pªí¥Ü¡AÀù¯gªvÀø¤è¦¡¤é·s¤ë²§¡A¬°¥[³t¨ú±o¥ý¶iÀù¯gÃÄ«~¡A¨Ã­ÝÅU°·«O¥ÃÄòµo®i¡A¤é«e¥Ñ°·«O¸pªø¥Û±R¨}¥Nªí»P­^°êNICEñ¸p¦X§@¨ó©w¡A¦@¦Pºë¶iÂåÀø¬ì§Þµû¦ô¡C

¾Ú½Ã¥ÍºÖ§Q³¡¤¤¥¡°·±d«OÀI¸pºô¯¸·s»D¡AÀù¯g¬°°ê¤H¤Q¤j¦º¦]¤§­º¥Bµo¥Í²v¤´«ùÄòÃk¤É¡Aªñ¦~¦]Àù¯gªvÀø¤è¦¡¤é·s¤ë²§¡A©úÅã½ÄÀ»°·«O¦³­­¸ê·½¡C¬°¥[³t¨ú±o¥ý¶iÀù¯gÃÄ«~¡A¨Ã­ÝÅU°·«O¥ÃÄòµo®i¡A½Ã¥ÍºÖ§Q³¡°·«O¸p¥Û±R¨}¸pªø¡B°ê¥Á°·±d¸p§d¬L­x¸pªø¤Î°]¹Îªk¤HÂåÃÄ«~¬dÅ礤¤ß(CDE)ªL®É©y°õ¦æªøµ¥¤H¡A©ó¥»©¡¥@¬É½Ã¥Í¤j·|(WHA)·|«e­u­^°ê¡A«ô³X­^°ê°ê®a°·±dº[·ÓÅ@¨ô¶V¬ã¨s°| (National Institute for Health and Care Excellence, NICE)¤Î­^°ê°ê¥Á°·±dªA°È¸p (National Health Service, NHS)©x­û¡A´N³Ð·sÃÄ«~°òª÷(Innovative Medicines Fund, IMF)¤ÎÀùÃÄ°òª÷(Cancer Drugs Fund, CDF)¹B§@¼Ò¦¡¡BÂåÀø¬ì§Þµû¦ô(HTA)¡B¦h¤¸°]°ÈºÞ±±¾÷¨îµ¥Ä³ÃD¶i¦æ¥æ¬y¡A¨Ã¥Ñ°·«O¸p¸pªø¥Û±R¨}¡BCDE°õ¦æªøªL®É©y©M­^°êNICE©ó¤µ(112)¦~5¤ë18¤é¦@¦Pñ¸p¦X§@¨ó©w¡A¥¼¨Ó±N²`¤ÆÂù¤è¸ê°T¥æ¬y¤Î¤H­û°V½m¡A¥H´£¤É°·«O·sÃĵ¹¥Iµû¦ô¤Î°]°ÈºÞ²z¾÷¨î¡C

NICE¬O­^°ê­t³d§ïµ½¨Ã°l¨D°·±d¤ÎªÀ·|·ÓÅ@Åé¨t¨ô¶Vµo®iªº¿W¥ß¾÷ºc¡A­t³d¨î©w°ª«~½è°·±d·ÓÅ@ªvÀø«ü¤Þ»P¼Ð·Ç¡A¥ç´N«P¶i°·±dªº¥Í¬¡¤è¦¡©M¹w¨¾¯e¯f´£¨Ñ«Øij¡CNICEªº¥Ø¼Ð«Y°ò©ó³Ì·sªº¹êÃÒ°ò¦¤U¡AÀ°§U NHS¡B¦a¤è¬F©²¡B·Oµ½¹ÎÅé¤ÎÂåÀø¡B¤½¦@½Ã¥Í»PªÀ·|ªA°È¤H­û¡Aµ½¥Î¦³­­¸ê·½´£¨Ñ³Ì¨Î·ÓÅ@¤Î¨ã¦¨¥»®Ä¯q¤Î»ù­ÈªºªvÀø¡A¥H´î¤ÖÂåÀø¤£¥­µ¥¡C

¦¹¦¸½ÃºÖ³¡«e©¹¦Ò¹î¡A¥D­n¬O§Æ±æÁA¸Ñ¦p¦ó¦b¦³­­¸ê·½¤U¡A¹B¥ÎHTA§Þ¥©¡AÅý¯f¤H¤Î¦­¨ú±o¬ð¯}©Ê·sÃÄ¡A¨Ã³z¹L¯u¹ê¥@¬É¼Æ¾Úªº¦¬¶°»Pµû¦ô¡AÅý¯Ê¥F¦¨¥»®Ä¯qªºÃÄ«~°h³õ¡A±N¸ê·½¥Î¦b¤M¤f¤W¡A¬°¨ãÂåÀø¤£½T©w©Ê¤§©ù¶Q·sÃÄ°ÝÃD´£¨Ñ¸Ñ¤è¡C

¥Û±R¨}¸pªø©ó·|½Í¤¤ªí¥Ü¡G¡u¤µ¤Ñ«D±`ºa©¯±a»â¥xÆW½ÃºÖ³¡¥Nªí¹Î«ô³X¦³24 ¦~±y¤[¾ú¥vªºNICE¡A¾Ç²ß¨ÉÅA¥þ²yªºÀùÃÄ°òª÷¨î«×¡C¦Ó¯à°÷¥Nªí½ÃºÖ³¡°·«O¸p»PNICE ñ­q¦X§@¨ó©w¡A¹ï©ó¹ê¬I¤F28 ¦~ªº¥xÆW°·«Oµo®i¥v¦Ó¨¥¡A§ó¬O­«­nªº¨½µ{¸O¡v¡C NICE¥ç»P¥[®³¤jªºCADTH¤Î¿D¬wPBACñ­q¦X§@¨ó©w¡A¨â¾÷ºc§¡¬°°ê»ÚHTA³»¦y¾÷ºc¡AÅã¥Ü°·«O¸p¤j¼Æ¾ÚºÞ²z»PCDE¦bHTA¤§ªí²{¨ü¨ìNICEªÖ©w¡C

NICE°ê»Ú¦X§@³¡°Æ¥D¥ô Pilar Pinilla-Dominguez·|¤¤´£¨ì¡G¡u§Ú­Ì«D±`¼Ö·N¤ä«ù¥xÆWºë¶iHTAµû¦ô¨t²Îªº±j¯P¥ø¹Ï¡A¤]¼ö¤Á§Æ±æ¥i¥H¤À¨ÉNICE¦b­^°êªº¸gÅç¡A³o¶µ¨ó©w¬°§Ú­Ì´£¨Ñ·¥¦nªº¾÷·|¡A¥i¥H¥æ¬y·Qªk¡B§ä¨ì¸Ñ¨MHTA¬ÛÃö¬D¾Ôªº¦@¦P¤èªk¡A¶i¦Ó³yºÖ§Ú­Ì¨â­Ó°ê®aªº¯f¤H¡v¡C

°·«O¸pªí¥Ü¡A¦¹¦¸Ã±¸p¦X§@¨ó©w¡AÂù¤è»EµJ¦bHTA¤§¤H­û°V½m¤Î§Þ³N¬ã°Q¡A¥¼¨Ó¥i³z¹L»PNICEªº²`¤J¦X§@¡A²Ä¤@¤â±µÄ²°ê»ÚHTAªº³Ì·sÁͶաBµû¦ô¬yµ{©M¤èªk¡A¤Î¯u¹ê¥@¬É¸ê®ÆªºÀ³¥Î¡B³Ð·sÃÄ«~°òª÷©MÀùÃÄ°òª÷ªº°]°È¹B§@µ¥¤è­±¶i¦æ¥R¤À¥æ¬y¡F¦Ó°·«O¸p¤]«D±`¼Ö·N»PNICE¤À¨É¦b¤j¼Æ¾ÚºÞ²z¤Î¤H¤u´¼¼z¹B¥Îªº³Ì·s¶i®i¡AÅý¦X§@¨ó©w§ó¥[¸¨¹ê»P¤¬´f¡C

¡i¹Ï¤ù¨Ó·½¡G¤¤¥¡ªÀ¡]°·«O¸p´£¨Ñ¡^¡j

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');